Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its price target raised by analysts at HC Wainwright from $2.00 to $10.00. They now have a "buy" rating on the stock.
Kiora Pharmaceuticals, Inc. (KPRX)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
KPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KPRX alerts
High impacting Kiora Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
KPRX
News
- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
- Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies [Yahoo! Finance]Yahoo! Finance
- Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation [Yahoo! Finance]Yahoo! Finance
- Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of Directors [Yahoo! Finance]Yahoo! Finance
- Corneal Ulcer Market to Increase at a Steady Growth Rate During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]Yahoo! Finance
KPRX
Earnings
- 8/9/24 - Beat
KPRX
Analyst Actions
- 8/22/24 - HC Wainwright
KPRX
Sec Filings
- 9/12/24 - Form 4
- 9/11/24 - Form 4
- 8/20/24 - Form 4
- KPRX's page on the SEC website